President Donald Trump speaks speaks on the latest developments of the coronavirus outbreak, while flanked by White House coronavirus response coordinator Debbie Birx (L), and U.S. Surgeon General Jerome Adams (R), in the James Brady Press Briefing Room at the White House March 19, 2020. (Photo by Chip Somodevilla/Getty Images)
President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases.
The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.
"We're going to be able to make that drug available almost immediately," Trump said.
The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.
He also tempered the president's optimism about the still-untested solution.
"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."
New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.
"The therapies are something we could move on much faster potentially," Trump said.
He claimed the administration "slashed red tape" to develop new vaccines and therapies.
The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks.
"If we find that we need something, then we will do that," he said.
Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak.
The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.
"We continue our relentless effort to defeat the Chinese virus," Trump said.
The Biden administration on Tuesday quietly launched its website for Americans to request free at-home COVID-19 tests, a day before the site was scheduled to officially launch.
Just 27% of voters aged 18-29 approve of the job Biden is doing as president, according to a survey from The Economist and YouGov late last year. Santiago Mayer, executive director of Voters of Tomorrow, joins Cheddar Politics to discuss why President Biden is losing support among young voters.
Jesse Lehrich, co-founder of Accountable Tech, joins Cheddar News to discuss it being one year since Trump was exiled from social media and the former President's new platform 'Truth Social.'
Cliff Albright, co-founder of the group Black Voters Matter, joins Cheddar Politics to discuss why he boycotted President Biden's voting rights speech this week, and the push from Senate Democrats to debate and vote on the Freedom to Vote Act and the John Lewis Voting Rights Advancement Act.
Senator Jon Ossoff (D-Ga.) has teamed up with fellow Democratic senator and former astronaut Mark Kelly to introduce the Ban Congressional Stock Trading Act, a bill to essentially end stock trading by sitting lawmakers. From the other side of the aisle, Senator Josh Hawley (R-Mo.) introduced his own legislation to enact something similar. The dueling bills come at a time when it's popular to constrain members of Congress from owning and trading stocks. Karl Evers-Hillstrom, a business and lobbying reporter at The Hill, spoke to Cheddar about the significance of the bills, and what they could mean for lawmakers, their families, and staffers moving forward.
A second Starbucks location in the U.S. has officially voted to unionize. On Monday, the National Labor Relations Board announced workers at the Starbucks store located in the Buffalo, NY suburb of Cheektowaga voted 15-9 in favor of being represented by Workers United, an affiliate of the Service Employees International Union. The New York Times reports votes were tallied in December but remained inconclusive as the union challenged the ballots of several employees it said did not work at the store. A Starbucks spokesperson has said that it may appeal the labor board's decision, which comes as several other Starbucks stores across the country are also pushing to form a union. Danka Dragic, shift supervisor for the second Starbucks store in the country to unionize, joined Cheddar News' Closing Bell to discuss.
